Status:
COMPLETED
Ultrasound Evaluation of Inferior Vena Cava Compression During Elective Cesarean Delivery.
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
Brief Summary
Aortocaval compression by the gravid uterus during the third trimester contributes to decreased venous return to the heart. Neuraxial anesthesia reinforces this hypotension by causing a vasodilatation...
Detailed Description
Cesarean delivery (CD) is one of the most currently practiced surgeries in the world. In 2013, surgical deliveries represented 32.4% of births in the United States and 26.9% in Canada. Maternal hypote...
Eligibility Criteria
Inclusion
- ASA 1-2
- Elective cesarean delivery
- Spinal anesthesia
- At least 37 weeks of gestational age
- French speaking patients (able to read and sign the consent form)
Exclusion
- Inability to obtain adequate ultrasound mesures before or after spinal anesthesia
- Cardiopathy
- Unexpected difficult spinal anesthesia requiring general anesthesia
- Unexpected complications requiring strong hemodynamic support (transfusions, volume challenges, multiple vasopressors, inotropic drugs...) or requiring anti-hypertensive medication (including magnesium)
- Any contraindication or patient's refusal for spinal anesthesia (e.g. coagulopathy)
- Morbid obesity (IMC over 40 at the time of delivery)
- Active labour
- Emergency cesarean delivery
- Fetal abnormality or prematurity (under 37 weeks of gestational age)
- Multiple gestation
- Inability to cooperate due to langage or physical/mental incapacity
Key Trial Info
Start Date :
January 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03410199
Start Date
January 29 2018
End Date
March 31 2018
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maisonneuve-rosemont
Montreal, Quebec, Canada, H1T2M4